BIOMAT Database Logo BIOMAT Database Logo

Double-blind comparison of 3- and 6-mg fixed doses of alprazolam vs. placebo in outpatients with major depressive disorder. 1989

R L Borison, and D Sinha, and J W Albrecht, and S Geber, and B I Diamond

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

R L Borison, and D Sinha, and J W Albrecht, and S Geber, and B I Diamond
A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder.
October 1983, Acta psychiatrica Scandinavica,
R L Borison, and D Sinha, and J W Albrecht, and S Geber, and B I Diamond
A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.
April 1992, Journal of clinical psychopharmacology,
R L Borison, and D Sinha, and J W Albrecht, and S Geber, and B I Diamond
Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder.
February 1986, Journal of clinical psychopharmacology,
R L Borison, and D Sinha, and J W Albrecht, and S Geber, and B I Diamond
Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study.
January 2014, Journal of psychiatry & neuroscience : JPN,
R L Borison, and D Sinha, and J W Albrecht, and S Geber, and B I Diamond
A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder.
November 2007, The Journal of clinical psychiatry,
R L Borison, and D Sinha, and J W Albrecht, and S Geber, and B I Diamond
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
February 1991, The Journal of clinical psychiatry,
R L Borison, and D Sinha, and J W Albrecht, and S Geber, and B I Diamond
A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40-120 mg/day) in patients with major depressive disorder.
January 2014, Journal of drug assessment,
R L Borison, and D Sinha, and J W Albrecht, and S Geber, and B I Diamond
A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
May 2014, Journal of child and adolescent psychopharmacology,
R L Borison, and D Sinha, and J W Albrecht, and S Geber, and B I Diamond
A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg/day in adult outpatients with major depressive disorder.
March 2013, BMC psychiatry,
R L Borison, and D Sinha, and J W Albrecht, and S Geber, and B I Diamond
Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
April 2002, The Journal of clinical psychiatry,
Copied contents to your clipboard!